Innate Pharma S.A.
IPHA | NASDAQ
$1.81
-$0.05 (-2.69%)
Sep 22, 2026, 2:20 PM ET · Market open
TTM Period Ending | TTM 2026 Jun 29, 2026 | TTM 2025 Dec 30, 2025 | TTM 2025 Jun 29, 2025 | TTM 2024 Dec 30, 2024 | TTM 2024 Jun 29, 2024 | TTM 2023 Dec 30, 2023 | TTM 2023 Jun 29, 2023 | TTM 2022 Dec 30, 2022 | TTM 2022 Jun 29, 2022 | TTM 2021 Dec 30, 2021 | TTM 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -3.16 | -2.71 | -2.81 | -2.91 | -4.51 | -25.69 | -3.61 | -4.84 | -8.88 | -5.99 | -2.83 |
PEG Ratio | 0.11 | -0.14 | 0.17 | 0.90 | -0.03 | 0.04 | 0.04 | 0 | 0.07 | -0.26 | 0.05 |
PS Ratio | 139.41 | 48.85 | 25.67 | 11.41 | 5.36 | 3.93 | 5.19 | 5.63 | 4.66 | 26.34 | 6.03 |
PB Ratio | -5 | 9.68 | 20.97 | 10.84 | 4.65 | 3.92 | 4.54 | 3.46 | 2.37 | 2.30 | 1.67 |
P/FCF Ratio | -3.37 | -2.36 | -2.99 | -19.76 | -8.42 | -6.20 | -6.93 | -13.78 | -7.46 | -5.34 | -8.20 |
P/OCF Ratio | -3.38 | -2.37 | -3 | -20.88 | -8.57 | -6.27 | -7.15 | -14.58 | -7.86 | -5.46 | -8.78 |
OCF/S Ratio | 226.51 | 214.12 | -2.15K | -1.79K | -51.40 | -79.92 | -137.79 | -120.30 | -485.05 | -653.92 | -155.93 |
Debt / Equity Ratio | -0.65 | 2.11 | 4.38 | 2.37 | 1 | 0.74 | 0.74 | 0.58 | 0.39 | 0.27 | 0.12 |
Quick Ratio | 0.94 | 1.74 | 2.40 | 2.76 | 3.33 | 3.78 | 3.61 | 2.86 | 2.03 | 2.39 | 3.34 |
Current Ratio | 0.94 | 1.74 | 2.40 | 2.76 | 3.33 | 3.78 | 3.61 | 2.86 | 2.03 | 2.39 | 3.38 |
Asset Turnover | 0.03 | 0.01 | 0.03 | 0.04 | 0.09 | 0.14 | 0.11 | 0.09 | 0.08 | 0.02 | 0.06 |
Interest Coverage | -68.29 | -4.88 | -371.50 | -393.43 | -23.15 | -9.33 | -161.32 | -153.21 | n/a | n/a | n/a |
Return on Equity | 88.23% | -143.79% | -347.31% | -182.84% | -51.95% | -7.46% | -57.98% | -56.76% | -10.83% | -22.42% | -26.08% |
Return on Assets | -50.68% | -33.52% | -22.61% | -19.30% | -10.82% | -2.22% | -15.06% | -14.37% | -4.31% | -9.89% | -13.18% |
Return on Invested Capital | -112.24% | -53.39% | -32.10% | -25.32% | -13.33% | -1.70% | -7.21% | -7.19% | -4.36% | -10.11% | -7.81% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -444.93% | -606.05% | 5.16K% | 5.25K% | -77.20% | 18.31% | -2.60% | 4.53% | -146.02% | -187.79% | 34.49% |
Net Profit Margin | 351.38% | 446.76% | -4.7K% | -4.58K% | -128.35% | -25.62% | -385.14% | -379.93% | -513.13% | -648.03% | -226.64% |
Pretax Profit Margin | 315.45% | 451.73% | -4.7K% | -4.58K% | -113.69% | -17.83% | -414.31% | -407.32% | -524.07% | -680.35% | -265.86% |
Operating Profit Margin | 329.25% | 413.71% | -4.84K% | -4.68K% | -128.97% | -29.83% | -180.76% | -168.27% | -548.13% | -695.79% | -174.86% |
FCF Margin | 227.12% | 215.52% | -2.17K% | -1.81K% | -52.67% | -80.49% | -142.46% | -125.04% | -503.37% | -673.53% | -160.40% |
EBITDA Margin | 394.54% | 482.76% | -4.13K% | -3.97K% | -134.93% | -30.22% | -59.46% | -53.11% | -474.15% | -622.69% | -240.67% |
Add to Watchlist
Select watchlists to add or remove IPHA